Header Logo

Connection

Sami Ibrahimi to Treatment Outcome

This is a "connection" page, showing publications Sami Ibrahimi has written about Treatment Outcome.
Connection Strength

0.168
  1. Sustained response to lenalidomide for early relapsed marginal zone lymphoma. Blood Cells Mol Dis. 2018 07; 71:53-54.
    View in: PubMed
    Score: 0.095
  2. Harnessing the PD-1 Pathway in Myelodysplastic Syndrome. Am J Ther. 2018 Nov/Dec; 25(6):e711-e712.
    View in: PubMed
    Score: 0.025
  3. Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. Am J Ther. 2018 May/Jun; 25(3):e394-e396.
    View in: PubMed
    Score: 0.024
  4. Extranodal Marginal Zone Lymphoma of the Central Nervous System. Clin Lymphoma Myeloma Leuk. 2018 01; 18(1):34-37.e8.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.